港股異動丨晶苑國際(2232.HK)連續兩日大漲 港府9月初將再派發“銅芯抗疫口罩”
格隆匯8月24日丨繼上週五漲8.43%後,“銅芯抗疫口罩”廠家晶苑國際(2232.HK)今日再度大漲16.67%,報2.1港元,總市值60億港元。香港創新及科技局局長薛永恆在電台節目中透露,當局預計於9月初,再派發可重用的“銅芯抗疫口罩”,供市民應付冬季可能出現的反覆疫情。香港創新及科技局指,已給市民免費派發共590萬個“銅芯抗疫口罩”,現時庫存有490萬個。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.